NEW YORK, NY / ACCESS Newswire / September 15, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=167503&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / September 15, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=167502&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Synopsys, Inc. ("Synopsys, Inc.") (NASDAQ:SNPS) concerning possible violations of federal securities laws. On September 9, 2025, Synopsis issued third quarter results far below expectations and the company’s own prior guidance. Full year

NEW YORK CITY, NY / ACCESS Newswire / September 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Gartner, Inc. ("Gartner, Inc.") (NYSE:IT) concerning possible violations of federal securities laws. On August 6, 2025, Gartner issued a press release announcing second quarter fiscal 2025 results, beating revenue and earnings

NEW YORK, NY / ACCESS Newswire / September 15, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=167500&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So What: If you purchased RxSight securities during the Class Period you may

We are advised by Desilo that journalists and other readers should disregard the news release, DESILO and Cornami Launch Encrypted AI Model That Balances Privacy and Performance, issued 09-Sep-2025 over PR Newswire, as the release contained information that requires clarification. This clarification notice is provided to ensure accurate understanding of the project's current status. DESILO

Robbins LLPreminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Tronox Holdings PLC (NYSE: TROX) common stock between February 12, 2025 and July 25, 2025. Tronox operates titanium-bearing mineral sand mines and processes them to produce titanium dioxide (TiO2) products. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg For more information, submit

NEW YORK CITY, NY / ACCESS Newswire / September 15, 2025 / If you suffered a loss on your Snap Inc. (NYSE:SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=167498&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Robbins LLPreminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg For more information, submit a form, emailattorney Aaron Dumas, Jr., or give